Fiera Capital (Canada)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1M Buy
78,822
+8,102
+11% +$2.76M 0.09% 171
2025
Q4
$28.1M Buy
70,720
+16,916
+31% +$7.49M 0.09% 161
2025
Q3
$24.5M Buy
53,804
+26,061
+94% +$10.6M 0.08% 158
2025
Q2
$9.05M Buy
27,743
+10,531
+61% +$2.91M 0.03% 193
2025
Q1
$4.65M Buy
17,212
+1,242
+8% +$319K 0.02% 231
2024
Q4
$3.76M Buy
+15,970
New +$4.2M 0.01% 232
2021
Q2
Sell
-3,700
Closed -$522K 574
2021
Q1
$522K Buy
3,700
+185
+5% +$27.8K ﹤0.01% 475
2020
Q4
$457K Buy
3,515
+800
+29% +$107K ﹤0.01% 541
2020
Q3
$395K Sell
2,715
-340
-11% -$48.3K ﹤0.01% 500
2020
Q2
$452K Buy
+3,055
New +$412K ﹤0.01% 491

Other funds holding ALNY